Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice

MLA

Gianni Cametti, et al. Overall Survival of Myelodysplastic Syndrome Patients after Azacitidine Discontinuation and Applicability of the North American MDS Consortium Scoring System in Clinical Practice. Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4e2c8238c360ef117119fefb031b34bb&authtype=sso&custid=ns315887.

APA

Gianni Cametti, Daniela Cilloni, Bernardino Allione, Paolo Danise, Emanuele Angelucci, Carmine Selleri, Flavia Salvi, Silvana Capalbo, Antonio Abbadessa, Manuela Ceccarelli, Monica Crugnola, Andrea Castelli, Massimo Catarini, Riccardo Centurioni, Fabio Guolo, Esther Oliva, Roberto Freilone, Catia Bigazzi, Pellegrino Musto, … Enrico Balleari. (2021). Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice.

Chicago

Gianni Cametti, Daniela Cilloni, Bernardino Allione, Paolo Danise, Emanuele Angelucci, Carmine Selleri, Flavia Salvi, et al. 2021. “Overall Survival of Myelodysplastic Syndrome Patients after Azacitidine Discontinuation and Applicability of the North American MDS Consortium Scoring System in Clinical Practice,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4e2c8238c360ef117119fefb031b34bb&authtype=sso&custid=ns315887.